The Canadian Bioceutical CBICF

BRIEF: 3 Concerns Related to MPX Bioceutical

[AwareInvestor]

We've been taking a deep dive in to MPX Bioceutical lately, and we plan to issue a full analysis on the company this coming Sunday. Overall we remain bullish on the company, however we had some concerns we wanted to address before we really got in to the full analysis of things. Check out these concerns we addressed below! If you have any comments or questions feel free to DM me at anytime

https://thedeepdive.ca/brief-3-concerns-related-mpx-bioceutical/

[Bossman87]

you have nothing in this that talks about the whole goal of the company. Point number 2 makes no sense in this article when a nr was posted explaining why the shareholder had to move out. I understand point 1 but if im not mistaken they have enough capital now to expand a lot more. Dillution is true but is needed for the long run. If the execution is there which it has been, we will be more than

[NewDonald]

This post has been removed in accordance with Community Policy

[Chevy_Chase]

Dilution is a concern. With a fully diluted 452 million shares outstanding, when this stocks trades at $1 per share, MPX will have a market cap of $452 million.  It will trade at less than 1 billion market cap at $2 per share, which would be less than the market caps of its peers.